Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PAOPA

Copy Product Info
😃Good

Synonyms:

Catalog No. T23121 Copy Product Info
😃Good
PAOPA belongs to natural product derivatives and serves as an allosteric modulator of the dopamine D2 receptor, possessing the characteristic of promoting binding between high-affinity D2 receptors and agonists. This compound finds application in preclinical studies for schizophrenia and extrapyramidal dysfunction, effectively alleviating behavioral and biochemical abnormalities in rodent models.
PAOPA
Cas No. 114200-31-6
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$148In StockIn Stock
5 mg$372In StockIn Stock
10 mg$612In StockIn Stock
25 mg$1,290In StockIn Stock
50 mg$1,980In StockIn Stock
100 mg$2,790In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
ee:99.84%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PAOPA belongs to natural product derivatives and serves as an allosteric modulator of the dopamine D2 receptor, possessing the characteristic of promoting binding between high-affinity D2 receptors and agonists. This compound finds application in preclinical studies for schizophrenia and extrapyramidal dysfunction, effectively alleviating behavioral and biochemical abnormalities in rodent models.
In vitro
Methods: D2/eYFP-labeled cells were treated with 10 μM PAOPA for 1.5 hours and 48 hours, respectively. GRK2, arrestin-3, phosphorylated ERK1/2 expression, and D2 receptor internalization were subsequently detected.
Results: Treatment for 1.5 hours increased striatal GRK2 expression and promoted the expression of arrestin-3, p-ERK1, and p-ERK2; treatment for 48 hours facilitated D2 receptor internalization. [1]
In vivo
Methods: In mice, PAOPA (1 mg/kg) was administered via intraperitoneal injection once daily for 45 consecutive days to evaluate its effects on D2 receptors and downstream molecules.
Results: Chronic administration induced D2 receptor modulation and increased the expression of downstream molecules GRK2, arrestin-3, and ERK1/2. [1]
Chemical Properties
Molecular Weight254.29
FormulaC11H18N4O3
Cas No.114200-31-6
SmilesN(C(=O)[C@@H]1CCCN1)[C@H]2C(=O)N(CC(N)=O)CC2
Relative Density.1.33 g/cm3 (Predicted)
Storage & Solubility Information
StorageKeep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (176.96 mM), Sonication is recommended.
H2O: <25.43 mg/mL, Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9325 mL19.6626 mL39.3252 mL196.6259 mL
5 mM0.7865 mL3.9325 mL7.8650 mL39.3252 mL
10 mM0.3933 mL1.9663 mL3.9325 mL19.6626 mL
20 mM0.1966 mL0.9831 mL1.9663 mL9.8313 mL
50 mM0.0787 mL0.3933 mL0.7865 mL3.9325 mL
100 mM0.0393 mL0.1966 mL0.3933 mL1.9663 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: PAOPA chemical structure | PAOPA in vivo | PAOPA in vitro | PAOPA formula | PAOPA molecular weight